What is Emergent Biosolutions's earnings yield?

Emergent Biosolutions (EBS) reported earnings yield of 16.1% in Q3 2025.

How has Emergent Biosolutions's earnings yield changed year-over-year?

Emergent Biosolutions's earnings yield increased by 134.1% year-over-year, from -47.3% to 16.1%.

What is the long-term trend for Emergent Biosolutions's earnings yield?

Over 4 years (2020 to 2024), Emergent Biosolutions's earnings yield has grown at a 55.3% compound annual growth rate (CAGR), from 6.3% to -36.8%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Emergent Biosolutions EBS Earnings yield

Earnings yield at other companies

Thermo Fisher ScientificTMO

3.8%+0.3pp

Regeneron PharmaceuticalsREGN

5.4%-1.1pp

AMP

Amphastar PharmaceuticalsAMPH

8.9%-1.3pp

Amneal Pharmaceuticals, Inc.AMRX

3.1%+2.7pp

CorMedixCRMD

33.7%—

Collegium Pharmaceutical, Inc.COLL

7.1%+2.6pp

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

net income/market cap=16.1%

Based on trailing twelve months.

The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's earnings yield?: Emergent Biosolutions (EBS) reported earnings yield of 16.1% in Q3 2025.
How has Emergent Biosolutions's earnings yield changed year-over-year?: Emergent Biosolutions's earnings yield increased by 134.1% year-over-year, from -47.3% to 16.1%.
What is the long-term trend for Emergent Biosolutions's earnings yield?: Over 4 years (2020 to 2024), Emergent Biosolutions's earnings yield has grown at a 55.3% compound annual growth rate (CAGR), from 6.3% to -36.8%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.